权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The Glucocorticoid Receptor as Signal Integrator: Studying All Drug Resistance

糖皮质激素受体作为信号积分器：研究所有耐药性

基本信息

批准号：
8473060
负责人：
MILES A PUFALL
金额：
$ 21.74万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-07-08 至 2014-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8473060
关键词：
Acute Lymphocytic Leukemia Adverse effects Allosteric Regulation Apoptosis Apoptotic Asthma Autoimmune Diseases Award B-Cell Acute Lymphoblastic Leukemia Binding Sites Biochemical Biology Calorimetry Cell Line Cells ChIP-seq Characteristics Childhood Chromatin Communication Complex Computing Methodologies Cues DNA DNA Binding DNA Binding Domain DNA Sequence Data Set Development Diabetes Mellitus Disease Drug resistance Drug usage Face Future Gene Expression Genes Genetic Transcription Genome Genomics Glucocorticoid Receptor Glucocorticoid-induced apoptosis Glucocorticoids Goals Health Hematopoietic Histone H3 Hormones Hypertension In Vitro Intervention Learning Lysine Malignant Neoplasms Maps Mass Spectrum Analysis Measures Messenger RNA Methods Modeling Modification Nuclear Extract Nuclear Magnetic Resonance Organ Transplantation Osteoporosis Outcome Output Pharmaceutical Preparations Pre-B Acute Lymphoblastic Leukemia Prednisone Property Proteins Reading Resistance Resources Response Elements Signal Pathway Signal Transduction Specific qualifier value Structural Models System Testing Thermodynamics Time Tissues Training Translating Work abstracting base career development cell type deep sequencing effective therapy experience genome-wide glucocorticoid-induced orphan receptor hormone resistance human tissue outcome forecast programs receptor receptor binding receptor function response screening transcription factor transcriptome sequencing

项目摘要

Project Summary/Abstract Proteins lie at the nodes of signaling pathways, and it is their task to integrate these signals to direct a specific output - one that is tailored to the needs of the cell at the time. Dr. Miles Pufall has studied signal integration using the glucocorticoid receptor (GR), in particular the mechanistic basis of allosteric regulation by DNA sequence. This K99/R00 award will provide him with the resources, time, and training to develop systems that translate the structural and biophysical basis of GR allosteric integration into an understanding of the signaling aberrations that result in childhood pre-B acute lymphoblastic leukemia (B-ALL) treatment resistance. This work will enable development of selective interventions that direct allosteric networks in the protein. This award will allow Dr. Pufall to achieve the following career development goals: 1) Develop a grounding in hematopoietic development and disease; 2) Learn to work with primary tissue; 3) Gain experience with genomic data sets to develop future studies; and 4) Develop an in vitro system to test signal integration principles. The glucocorticoid receptor orchestrates a program of gene expression in response to cellular signals by nucleating the assembly of regulatory complexes at specific DNA response elements throughout the genome. In B-ALL, synthetic glucocorticoids directed against GR are an effective treatment, which in combination with other drugs, work to induce an apoptotic program. However those who do not respond to glucocorticoids face a grim prognosis. Dr. Pufall hypothesizes that signaling pathways that allosterically regulate GR have been disrupted, changing the normal function of the receptor, and blocking apoptosis. He will test this hypothesis in three aims: 1) Identify changes in glucocorticoid induced gene expression programs, GR binding, and marks for active chromatin in glucocorticoid sensitive and resistant acute lymphoblastic leukemia; 2) Purify GR regulatory complexes from select response elements and identify components; and 3) Identify allosteric wires emanating from the DNA binding domain of GR, and determine how signals impinge on these wires.

项目总结/摘要蛋白质位于信号通路的节点，它们的任务是整合这些信号以指导特定的输出-一个是定制的细胞的需要在当时。Miles Pufall博士研究了信号整合利用糖皮质激素受体（GR），特别是DNA变构调节的机制基础顺序这个K99/R 00奖项将为他提供资源、时间和培训来开发系统将GR变构整合的结构和生物物理学基础转化为对导致儿童前B急性淋巴细胞白血病（B-ALL）治疗的信号异常阻力这项工作将使选择性干预的发展，直接变构网络在蛋白该奖项将使Pufall博士实现以下职业发展目标：1）培养一个造血发育和疾病的基础; 2）学习与初级组织合作; 3）获得基因组数据集的经验，以开发未来的研究;和4）开发体外系统，以测试信号融合原则。糖皮质激素受体通过以下方式协调响应细胞信号的基因表达程序：使整个基因组中特定DNA反应元件处的调节复合物的组装成核。在B-ALL中，针对GR的合成糖皮质激素是一种有效的治疗方法，其他的药物，可以诱导细胞凋亡。然而，那些对糖皮质激素没有反应的人面临严峻的预后。Pufall博士假设，变构调节GR的信号通路具有被破坏，改变受体的正常功能，并阻断细胞凋亡。他会测试这个假设有三个目的：1）鉴定糖皮质激素诱导的基因表达程序，GR结合，糖皮质激素敏感和耐药的急性淋巴细胞白血病中活性染色质的标记; 2）从选择的响应元件纯化GR调节复合物并鉴定组分;和从GR的DNA结合域发出的变构丝，并确定信号如何冲击这些电线.